The aldo-keto reductase (AKR) superfamily is a rapidly growing group of NAD(P)(H)-dependent oxidoreductases that metabolize carbohydrates, steroids, prostaglandins, and other endogenous aldehydes and ketones, as well as xenobiotic compounds.
The aldo-keto reductase (AKR) superfamily is a rapidly growing group of NAD(P)(H)-dependent oxidoreductases that metabolize carbohydrates, steroids, prostaglandins, and other endogenous aldehydes and ketones, as well as xenobiotic compounds. 1, 2) Members of this superfamily were classified into 14 families, and each family is subdivided into several subfamilies based on their amino acid sequence similarities. Among the subfamilies, AKR1C is the largest one, which includes mammalian hydroxysteroid dehydrogenases (HSDs), prostaglandin F synthases and related proteins. To date, four members of this subfamily were identified in humans: 20a-HSD (AKR1C1), 3a-HSD type 3 (AKR1C2), 17b-HSD type 5 (also called 3a-HSD type 2 and prostaglandin F synthase; AKR1C3) and 3a-HSD type 1 (AKR1C4). 3, 4) These members exhibit dihydrodiol dehydrogenase and carbonyl reductase activities for dihydrodiols of aromatic hydrocarbons and xenobiotic carbonyl compounds, and their genes share similar structural organization and are clustered on chromosome 10p15. In mice, a cluster of genes for eight members of the AKR1C subfamily was found on mouse chromosome 13. 5) Three of these mouse members are 20a-HSD (AKR1C18), 6) 3a-HSD (AKR1C14) 7) and 17b-HSD type 5 (AKR1C6), 8) two are dual functional 3a(17b)-HSD (AKR1C20) 9 ) and 3(17)a-HSD (AKR1C21), 10) and the others are reported to be aldo-keto reductases (AKR1C12, 11) AKR1C13 11) and AKR1C19 12) ). The five mouse HSDs are NADP(H)-dependent, whereas the three mouse aldo-keto reductases show dual coenzyme specificity for NADPH and NADH or preference for NADH. The expression of the eight mouse enzymes in the tissue differs between themselves. 5) AKR1C12 and AKR1C13 are unique in their high expression in epithelial cells of mouse stomach and have been proposed to be involved in detoxification of xenobiotic carbonyl compounds in the stomach.
11) Interestingly, AKR1C12 is identical to a protein (AKRa) that is encoded in an interleukin-3-regulated gene in mouse myeloid cells, suggesting that the enzyme also plays a role in the myeloid cell differentiation. 13) However, there has been only one report on the properties of AKR1C12, in which two xenobiotic carbonyl compounds, 9,10-phenanthrenequinone (PQ) and 4-nitrobenzaldehyde, were found to be good substrates. 11) Thus, the endogenous substrates of the enzyme remain unknown, and its ability to oxidize alcohol substrates has not been studied. In this study, we have examined the coenzyme and substrate specificity of recombinant AKR1C12 in both reduction and oxidation directions at physiological pH in order to elucidate the function related to the high expression levels in the stomach and myeloid cell differentiation.
MATERIALS AND METHODS
cDNA Isolation and Enzyme Purification The cDNA (nucleotides 1-977) for AKR1C12 was amplified from a total RNA of an ICR mouse liver by reverse transcription (RT)-PCR. The preparation of the total RNA and RT were preformed as described previously. 14) In the PCR, Pfu DNA polymerase was used together with a sense primer (5Ј-AT-GAGCTCCAAACAGCACTA) and antisense primer (5Ј-CCATGTTAATATTCCTCCGA), which were designed based on the sequence of the cDNA for AKRa.
13) The PCR products were subcloned into the pCR T7/CT-TOPO vectors (Invitrogen), and the expression constructs were transfected into Escherichia coli BL21 (DE3) pLysS according to the protocol described by the manufacturer. The sequences of the inserts were verified by DNA sequencing with a CEQ2000XL DNA sequencer (Beckman Coulter).
The E. coli cells were cultured in a LB medium containing ampicillin (50 mg/ml) at 37°C until the absorbance at 600 nm reached 0.5. Then isopropyl-1-thio-b-D-galactopyranoside (1 mM) was added, and the culture was continued for 24 h at 20°C. The cells were collected and the extract was prepared as described previously.
14) The recombinant AKR1C12 was Assay of Enzyme Activity Reductase and dehydrogenase activities of the recombinant enzyme were assayed by measuring the rate of change in NAD(P)H absorbance (at 340 nm) and its fluorescence (at 455 nm with an excitation wavelength of 340 nm), respectively. The standard reaction mixture for the reductase activity consisted of 0.1 M potassium phosphate, pH 7.4, 0.1 mM NAD(P)H, substrate and enzyme, in a total volume of 2.0 ml. The dehydrogenase activity was determined with 1 mM NAD(P) ϩ and 1 mM (S)-(ϩ)-1,2,3,4-tetrahydro-1-naphthol (S-tetralol) as the coenzyme and substrate, respectively, in the standard reaction mixture. TBE and trans-benzene dihydrodiol were synthesized as described previously. 16, 17) Other substrates were of the highest grade that could be obtained commercially. One unit (U) of enzyme activity was defined as the amount that catalyzes the reduction or formation of 1 mmol NAD(P)H per min at 25°C. The pH dependency of the oxidoreduction catalyzed by AKR1C12 was examined with 0.1 M potassium phosphate buffers (pH 5.5-11.0), which were prepared by mixing the solutions of phosphoric acid and tripotassium phosphate. The apparent K m and k cat values were determined over a range of five substrate concentrations at a saturating concentration of coenzyme by fitting the initial velocities to the MichaelisMenten equation. The kinetic constants and IC 50 values are expressed as the means of two determinations.
Product Identification To identify products of the reduction and oxidation of steroidal substrates, the reaction was conducted in a 2.0 ml system containing 0.1 mM NAD(H), substrate (20-50 mM), enzyme (3 mg), and 0.1 M potassium phosphate, pH 6.5. The substrate and products were extracted into 6 ml ethyl acetate at 30 min after the reaction was started at 37°C, and analyzed by liquid chromatography/mass spectrometry (LC/MS) as described previously. 6) RESULTS AND DISCUSSION Expression and Purification of AKR1C12 The amino acid sequence deduced from the isolated cDNA for AKR1C12 differs from that for mouse stomach AKR1C12 11) only by two amino acids at positions 81 and 179, but is the same as those for AKRa of BALB/c mouse 13) and a transcript of the AKR1C12 gene of CL57BL/6J mice (accession no. NM_013777). Although the mouse strain is not specified for the mouse stomach AKR1C12, the difference in the amino acid sequences is probably due to the strain difference, because only one gene for AKR1C12 has been identified by genomic analysis 5) and an cDNA for AKR1C12 with a replacement of the amino acid at position 81 (accession no. BC063780) is also isolated from a FVB/N mouse colon. Recombinant AKR1C12 was highly expressed from the cDNA in the E. coli cells, and detected as a major 36-kDa protein by SDS-PAGE analysis of the cell extract (Fig. 1) . The extract showed NADPH-linked reductase activity (0.15 U/mg) towards 10 mM PQ at pH 7.4. When NADH was employed as the coenzyme, higher reductase activity towards PQ (0.25 U/mg) was observed, as reported for mouse stomach AKR1C12.
11) The cell extract also exhibited NADH-linked reductase activity towards 0.1 mM S-camphorquinone (0.09 U/mg) and NAD ϩ -linked dehydrogenase activities towards 1 mM S-tetralol (0.18 U/mg) and S-indan-1-ol (0.19 U/mg). The control E. coli cells transfected with the vector alone showed both NADPH-and NADH-dependent reductase activities towards PQ (approximately 0.03 U/mg), whereas no significant dehydrogenase activity towards Stetralol was observed. Therefore, the recombinant protein was purified by assaying NAD ϩ -linked S-tetralol dehydrogenase activity. The final preparation with a specific activity of 0.35 U/mg was greater than 97% pure (Fig. 1) , and the purification yield was 40% (26 mg/l of the cultured cells).
Coenzyme Specificity In the previous study on AKR1C12, only the K m values of AKR1C12 for NADPH and NADH were determined using PQ as the substrate at pH 6.5, but the coenzyme specificity in the reverse reaction was not examined.
11) It was reported that the time course of PQ reduction by NAD(P)H-dependent reductases is proceeded by redox cycling of the quinone and its hydroquinone until NADPH is completely oxidized. [18] [19] [20] Indeed, similar phenomenon was observed in the NAD(P)H-linked PQ reduction by the purified AKR1C12 (data not shown). Therefore, we re-examined the coenzyme specificity by determining the K m and k cat values for the coenzymes in both S-camphorquinone reduction and S-tetralol oxidation at a physiological pH of 7.4. The enzyme showed coenzyme preference for NADH (K m ϭ4.0 mM and k cat /K m ϭ12.6 min Ϫ1 mM
Ϫ1
) over NADPH (K m ϭ70 mM and k cat /K m ϭ1.7 min Ϫ1 mM
). The K m value for S-camphorquinone (5.1 mM) in the presence of 0.1 mM NADH was also lower than that (16 mM) determined using 0.1 mM NADPH. Even in the oxidation of 1 mM S-tetralol,
) was a better coenzyme than NADP ϩ (K m ϭ331 mM and k cat /K m ϭ 0.04 min Ϫ1 mM
), and the K m values for S-tetralol in the presence of 1 mM NAD ϩ and NADP ϩ were 90 and 530 mM, respectively. Thus, AKR1C12 exhibits a pronounced preference for NAD(H) at a physiological pH 7.4.
Because the predominant forms of nucleotide coenzymes in mammalian cells are NAD ϩ and NADPH, 21, 22) it is generally believed that NAD(H)-dependent dehydrogenases function mainly in the oxidative direction, whereas the NADPHdependent enzymes function as reductases. 23 ) NAD ϩ , but not NADP ϩ , significantly inhibited both NADPH-and NADHlinked reductase activities of AKR1C12 (Fig. 2) , and less than 20% of the activities were retained in the presence of a cellular NAD ϩ concentration of 2 mM. 22) In case of the oxidation of S-tetralol using the coenzyme cellular concentrations of NAD ϩ and NADP ϩ , the NADP ϩ -linked activity was significantly inhibited by NADH, whereas the inhibition of the NAD ϩ -linked activity by NADH and NADPH was relatively low. These results indicate that AKR1C12, which was previously described as a reductase, 11) acts as a NAD
Substrate Specificity The recombinant AKR1C12 reduced various a-dicarbonyl compounds, aldehydes and some ketones, in addition to the known substrates, PQ and 4-nitrobenzaldehyde, in the presence of NADH as the coenzyme (Table 1 ). The enzyme also reduced 3-, 17-and 20-ketosteroids at low rates, although no significant activity was observed towards short-chain aliphatic aldehydes (1-propanal, 1-butanal and hexanal) and other ketones (4-nitroacetophenone, 4-benzoylpyridine, propiophenone, acetone, menadione and PGD 2 ). The reduced products of 5b-androstan-3a-ol-17-one and 17a-hydroxyprogesterone were identified as 5b-androstane-3a,17b-diol and 4-pregnene-17a,20a-diol-3-one, respectively, by the LC/MS analysis. In the reduction of 5b-androstane-3,17-dione, three products, 5b-androstan17b-ol-3-one, 5b-androstane-3a,17b-diol and 5b-androstan3a-ol-17-one, were formed. The results suggest that the enzyme exhibits 3a-, 17b-and 20a-HSD activities.
In the reverse reaction using NAD ϩ as the coenzyme, AKR1C12 oxidized various non-steroidal alicyclic alcohols and long-chain aliphatic alcohols, of which geranylgeraniol (GGOH) was the best substrate, exhibiting the lowest K m and highest k cat /K m values ( Table 2 ). The enzyme oxidized 20a-, 17b-and 3a-hydroxysteroids, and the oxidized products of 4-pregnen-20a-ol-3-one, 5a-androstan-17b-ol-3-one and 4-androsten-3a-ol-17-one were identified as progesterone, 5a-androstane-3,17-dione and 4-androstene-3,17-dione, respectively, by the LC/MS analysis. Although the k cat values for the hydroxysteroids were low, k cat /K m values for many hydroxysteroids were relatively high due to their low K m values when compared with those for non-steroidal alicyclic alcohols. This suggests that the hydroxysteroids are endogenous substrates of AKR1C12.
Comparison with Other Rodent Enzymes in the AKR1C Subfamily The broad substrate specificity of AKR1C12 for 3a-, 17b-and 20a-hydroxysteroids is clearly distinct from NADP(H)-dependent mouse HSDs (AKR1C6, AKR1C14, AKR1C18, AKR1C20 and AKR1C21), which catalyze the oxidoreduction of hydroxyl groups at one or two positions on the steroid substrate. [6] [7] [8] [9] [10] AKR1C12 is also different from NAD(H)-preferring mouse aldo-keto reductases (AKR1C13 and AKR1C19), which do not show significant HSD activity. 11, 12) On the other hand, the substrate specificity of AKR1C12 for both steroids and non-steroidal alicyclic alcohols are similar to that of AKR1C24, which has recently been identified as a novel type of NAD(H)-preferring 17b-HSD. 24) The pH optima of the NADH-linked S-camphorquinone reductase and NAD 10.5, respectively, which are also the same as those of AKR1C24. Additionally, the NAD ϩ -linked S-tetralol dehydrogenase of AKR1C12 was inhibited by hexestrol, dienstrol, zearalenone and genistein (IC 50 values were 1.5, 5.0, 4.7 and 40 mM, respectively), which show similar inhibitory potency for AKR1C24. Furthermore, the amino acid sequences of AKR1C12 and AKR1C24 are 91% identical. Therefore, AKR1C12 and AKR1C24 are identical enzyme species.
Role of AKR1C12 It has been proposed that AKR1C24 plays a role in the inactivation of androgen and estrogen, and the production of active progesterone in the gastrointestinal tract and other tissues of rats.
24) The tissue expression patterns of the mRNAs for AKR1C24 24) and AKR1C12 5) are almost the same. The identification of AKR1C12 with the mouse counterpart of AKR1C24 further supports the proposed physiological role of this enzyme species in the steroid metabolism. In addition, we emphasize another role of this enzyme in the metabolism of GGOH. As AKR1C12 did, AKR1C24 efficiently oxidized GGOH (K m ϭ0.6 mM and k cat /K m ϭ2.8 min Ϫ1 mM
) in our preliminary study. GGOH, an intermediate product in the mevalonate pathway, is utilized for protein prenylation, a post-translational maturation of diverse proteins involved in cell proliferation. [25] [26] [27] The exposure of GGOH to the cultured cells also results in the inhibition of cell proliferation, 28) apoptosis, 29, 30) and activation of peroxisome proliferators-activated receptors (a and g). 31) In contrast to the biological actions of GGOH, literature on its metabolism is little. GGOH is suggested to be metabolized to its diphosphate product by a kinase, 25) and to geranylgeranoic acid via geranylgeranial by aldehyde and alcohol dehydrogenases. 32) In rat thymocytes, GGOH is metabolized to (R)-2,3-dihydrogeranylgeranoic acid. 33) However, there is no study on the enzymes responsible for these metabolisms of GGOH. The present study is the first report that identifies the GGOH-metabolizing enzyme with high catalytic activity. GGOH is contained in many plants, which are ingested as herbal medicines and dietary foods. 31) The exogenous GGOH is probably diffused into the cells as demonstrated in previous studies on its biological actions and metabolism using cultured cells. [25] [26] [27] [28] [29] [30] [31] 33) The high expression of AKR1C12 and AKR1C24 in the rodent gastrointestinal tract, together with their high catalytic activity towards GGOH, suggests their roles in the metabolism of ingested GGOH to prevent its biological effects on the cells of the tissues. On the other hand, AKR1C12 is identical to AKRa that is encoded in the interleukin-3-regulated gene in mouse myeloid cells, in which the enzyme is thought to be involved in the production or catabolism of autocrine factors that promote the proliferation and/or lineage commitment of early myeloid progenitors.
13) The newly found substrates, GGOH and the hydroxysteroids, of the enzyme may be the autocrine factors required in the differentiation of myeloid cells, although further studies are needed to understand the significance of the up-regulation of the enzyme expression in hematopoiesis. 
